Norges Bank Pacira Bio Sciences, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

49 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $5.36 Million - $6.62 Million	210,057 New	210,057 $6.01 Million
Q4 2023 Feb 09, 2024	BUY	$26.32 - $34.31 $7.44 Million - $9.7 Million	282,803 New	282,803 $9.54 Million
Q3 2023 Nov 13, 2024	BUY	$30.68 - $40.09 $9.19 Million - $12 Million	299,548 New	299,548 $9.19 Million
Q3 2023 Nov 13, 2023	SELL	$30.68 - $40.09 $12.4 Million - $16.1 Million	-402,833 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$36.12 - $47.5 $3.74 Million - $4.92 Million	103,550 Added 49.3%	313,607 $12.6 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $14.6 Million - $19.1 Million	-403,102 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$35.53 - $43.38 $14.3 Million - $17.5 Million	403,464 New	403,464 $16.5 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $15.4 Million - $23.1 Million	402,833 New	402,833 $15.6 Million
Q3 2022 Nov 13, 2023	BUY	$51.24 - $58.89 $20.6 Million - $23.7 Million	402,833 New	402,833 $21.4 Million
Q2 2022 Aug 14, 2023	BUY	$51.49 - $81.64 $20.8 Million - $32.9 Million	403,102 New	403,102 $23.5 Million
Q1 2022 May 12, 2023	BUY	$60.03 - $76.49 $812,085 - $1.03 Million	13,528 Added 3.36%	416,361 $31.8 Million
Q1 2022 May 09, 2022	SELL	$60.03 - $76.49 $23.5 Million - $29.9 Million	-391,508 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$47.97 - $62.21 $18.8 Million - $24.4 Million	391,508 New	391,508 $23.6 Million
Q3 2021 Nov 14, 2022	BUY	$54.64 - $61.3 $14.2 Million - $15.9 Million	259,526 New	259,526 $14.5 Million
Q3 2021 Nov 05, 2021	SELL	$54.64 - $61.3 $16.4 Million - $18.4 Million	-300,604 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$59.18 - $69.99 $17.8 Million - $21 Million	300,604 New	300,604 $18.2 Million
Q2 2021 Aug 10, 2021	SELL	$59.18 - $69.99 $22.1 Million - $26.2 Million	-373,900 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$59.31 - $78.82 $22.2 Million - $29.5 Million	373,900 New	373,900 $26.2 Million
Q1 2021 May 07, 2021	SELL	$59.31 - $78.82 $28 Million - $37.1 Million	-471,312 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$50.47 - $66.26 $23.8 Million - $31.2 Million	471,312 New	471,312 $28.2 Million
Q4 2020 Feb 10, 2021	SELL	$50.47 - $66.26 $23.8 Million - $31.2 Million	-471,312 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$51.97 - $63.0 $24.5 Million - $29.7 Million	471,312 New	471,312 $28.3 Million
Q3 2020 Nov 10, 2020	SELL	$51.97 - $63.0 $28.2 Million - $34.2 Million	-542,667 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$30.8 - $52.47 $16.7 Million - $28.5 Million	542,667 New	542,667 $28.5 Million
Q2 2020 Aug 07, 2020	SELL	$30.8 - $52.47 $16.7 Million - $28.4 Million	-541,213 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$28.4 - $50.7 $15.4 Million - $27.4 Million	541,213 New	541,213 $18.1 Million
Q1 2020 May 08, 2020	SELL	$28.4 - $50.7 $15.4 Million - $27.4 Million	-541,213 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$36.31 - $46.83 $19.7 Million - $25.3 Million	541,213 New	541,213 $24.5 Million
Q4 2019 Feb 12, 2020	SELL	$36.31 - $46.83 $20.6 Million - $26.5 Million	-566,051 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$35.66 - $44.99 $20.2 Million - $25.5 Million	566,051 New	566,051 $21.6 Million
Q3 2019 Nov 08, 2019	SELL	$35.66 - $44.99 $19.6 Million - $24.7 Million	-549,551 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$36.57 - $47.97 $20.1 Million - $26.4 Million	549,551 New	549,551 $23.9 Million
Q2 2019 Aug 09, 2019	SELL	$36.57 - $47.97 $16.1 Million - $21.1 Million	-440,137 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$36.47 - $42.17 $872,690 - $1.01 Million	23,929 Added 5.75%	440,137 $16.8 Million
Q4 2018 Mar 04, 2019	BUY	$41.31 - $52.16 $17.2 Million - $21.7 Million	416,208 New	416,208 $17.9 Million
Q4 2018 Feb 08, 2019	SELL	$41.31 - $52.16 $15.4 Million - $19.5 Million	-373,781 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$32.85 - $52.0 $12.3 Million - $19.4 Million	373,781 New	373,781 $18.4 Million
Q3 2018 Nov 09, 2018	SELL	$32.85 - $52.0 $7.92 Million - $12.5 Million	-241,188 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$27.5 - $39.8 $6.63 Million - $9.6 Million	241,188 New	241,188 $7.73 Million
Q2 2018 Jul 23, 2018	SELL	$27.5 - $39.8 $11.3 Million - $16.3 Million	-409,566 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$29.98 - $46.35 $12.3 Million - $19 Million	409,566 New	409,566 $12.8 Million
Q1 2018 May 09, 2018	SELL	$29.98 - $46.35 $10.8 Million - $16.7 Million	-360,068 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$31.85 - $46.95 $11.5 Million - $16.9 Million	360,068 New	360,068 $16.4 Million
Q4 2017 Feb 09, 2018	SELL	$31.85 - $46.95 $11.5 Million - $16.9 Million	-360,068 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$35.7 - $39.5 $12.9 Million - $14.2 Million	360,068 New	360,068 $13.5 Million
Q3 2017 Nov 07, 2017	SELL	$35.7 - $39.5 $12.9 Million - $14.2 Million	-360,068 Closed	0 $0
Q2 2017 Jul 24, 2018	BUY	N/A	27,849 Added 8.38%	360,068 $17.2 Million
Q1 2017 May 11, 2018	SELL	N/A	-78,248 Reduced 19.06%	332,219 $15.1 Million
Q3 2016 Nov 13, 2017	BUY	N/A	410,467	410,467 $0

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account